| Literature DB >> 32587341 |
M L Aslam1, D Robledo2, A Krasnov1, H K Moghadam3, B Hillestad3, R D Houston2, M Baranski4, S Boison4, N A Robinson5,6.
Abstract
Salmonid alphavirus infection results in pancreas disease causing severe economic losses for Atlantic salmon aquaculture. Knowledge about genes and pathways contributing to resistance is limited. A 54 K SNP panel was used to genotype 10 full-sibling families each consisting of ~ 110 offspring challenged with salmonid alphavirus subtype 3. Relative heart viral load was assessed at 4- and 10-weeks post-infection using quantitative PCR. A moderate genomic heritability of viral load at 4 weeks (0.15-0.21) and a high positive correlation with survival (0.91-0.98) were detected. Positions of QTL detected on chromosome 3 matched those for survival detected by other studies. The SNP of highest significance occurred in the 3' untranslated region of gig1, a fish-specific antiviral effector. Locus B of immunoglobulin heavy chain mapped to an area containing multiple SNPs with genome-wide association. Heart mRNA-seq comparing parr from families with high- versus low-genomic breeding value, and matching sample genotypes for SNPs, identified two eQTL for salmonid alphavirus load. Immune genes associated with trans-eQTL were numerous and spread throughout the genome. QTL regions contained several genes with known or predicted immune functions, some differentially expressed. The putative functional genes and variants identified could help improve marker-based selection for pancreas disease resistance.Entities:
Mesh:
Year: 2020 PMID: 32587341 PMCID: PMC7316828 DOI: 10.1038/s41598-020-67405-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Summary of SAV RT-qPCR cycle threshold (Ct) results.
| Sampling time | Challenge type | EBV group | n | Mean | SD | Minimum | Maximum |
|---|---|---|---|---|---|---|---|
| W4 | CH | H | 141 | 17.99 | 2.01 | 11.96 | 24.48 |
| W4 | CH | L | 125 | 17.47 | 1.66 | 12.58 | 23.20 |
| W4 | IP | H | 140 | 23.28 | 2.08 | 17.02 | 30.16 |
| W4 | IP | L | 116 | 22.65 | 2.18 | 17.32 | 30.32 |
| W10 | CH | H | 122 | 27.50 | 2.02 | 22.47 | 38.09 |
| W10 | CH | L | 85 | 26.53 | 1.51 | 22.80 | 33.21 |
| W10 | IP | H | 131 | 29.98 | 3.15 | 24.63 | 39.23 |
| W10 | IP | L | 107 | 29.99 | 3.52 | 18.68 | 39.89 |
Ct is negatively related to relative viral load. Salmon with high or low estimated genomic breeding values (H or L gEBV group respectively) were infected for the challenge test trials by intraperitoneal injection (IP) or cohabitation with infected fish (CH). Testing occurred 4 weeks post-infection (W4) and 10 weeks post-infection (W10).
Heritability estimates for survival (dead or alive, ) and relative SAV3 viral load (SAV3 RT-qPCR cycle threshold, ) phenotypes at W4.
| Traits | ||
|---|---|---|
| IP | CH | |
| 0.40 (0.13) | 0.74 (0.08) | |
| 0.15 (0.06) | 0.21 (0.07) | |
Salmon were infected for the challenge test trials by intraperitoneal injection (IP) or cohabitation with infected fish (CH). Standard errors in parentheses.
Genetic correlations for relative SAV3 viral load (SAV3 RT-qPCR cycle threshold, Ct) between sampling times (W4 and W10) and across and within challenge types.
| Comparison | Correlation (standard error) |
|---|---|
| W4 vs. W10 (CH) | 0.58 (0.35) |
| W4 vs. W10 (IP) | 0.99 (0.26) |
| CH vs. IP | 0.73 (0.20) |
Standard errors in parentheses.
IP intraperitoneal injection, CH cohabitation with infected fish.
SNPs with genome- and chromosome-wide significant associations with relative SAV viral load in CH and IP trials.
| CHR | SNP | Pos (bp) | A1 | A2 | MAF | SE | ||
|---|---|---|---|---|---|---|---|---|
| 3 | AX-87986229 | 26488333 | A | C | 0.34 | − 0.74 | 0.17 | 7.43E−06 |
| 3 | AX-87865538 | 30994059 | A | G | 0.34 | − 0.72 | 0.16 | 1.2E−05 |
| 3 | AX-96308943 | 31004919 | C | T | 0.37 | − 0.74 | 0.16 | 2.63E−06 |
| 3 | AX-87618835 | 34527144 | T | C | 0.27 | − 0.74 | 0.17 | 9.06E−06 |
| 3 | AX-87849339 | 63236952 | G | A | 0.49 | 0.83 | 0.16 | 1.28E−07 |
| 3 | AX-96264043 | 76082530 | C | A | 0.30 | − 0.73 | 0.16 | 3.36E−06 |
| 3 | AX-96455227 | 76082537 | C | A | 0.30 | − 0.74 | 0.16 | 2.48E−06 |
| 3 | AX-88146078 | 77489246 | A | G | 0.22 | − 0.78 | 0.19 | 2.51E−05 |
| 3 | AX-88163075 | 8678000 | T | C | 0.17 | − 0.88 | 0.21 | 2.66E−05 |
| 3 | AX-98305314 | 82718110 | G | T | 0.30 | − 0.68 | 0.16 | 1.99E−05 |
| 3 | AX-88293328 | 83391111 | T | C | 0.49 | 0.85 | 0.16 | 1.94E−07 |
| 3 | AX-88010358 | 84875109 | C | T | 0.36 | − 0.63 | 0.15 | 2.44E−05 |
| 3 | AX-96235336 | 89833309 | A | G | 0.47 | 0.69 | 0.15 | 4.58E−06 |
| 3 | AX-88234566 | 89963083 | C | T | 0.48 | 0.83 | 0.16 | 4.1E−07 |
| 3 | AX-88122450 | 90830375 | C | G | 0.39 | 0.58 | 0.13 | 7.96E−06 |
| 3 | AX-87885147 | 81776059 | A | C | 0.21 | − 1.20 | 0.26 | 5.33E−06 |
| 3 | AX-88130071 | 82718000 | C | T | 0.19 | − 1.22 | 0.28 | 1.07E−05 |
Pos (bp) physical position of SNP in base pairs, A1 & A2 minor & major alleles, respectively, MAF minor allele frequency, α Allele substitution effect, SE standard error, P significance value.
Figure 1Manhattan plots of GWAS p-values for relative SAV3 viral load (− Ct) distributed across all chromosomes and for positions across Ssa03. Markers crossing genome and/or chromosome wide Bonferroni threshold are dotted in green colour. Results from the CH challenge trial (A, C) and the IP trial (B, D) are shown for SNPs on all chromosomes (A, B) and for SNPs on Ssa03 (C, D).
Figure 2Histograms showing counts of sequences of IGH locus mapping across Ssa03 (positions in Mega base pairs, Mbp). Location of immune genes and SNPs significantly associated with Ct (red asterisks) are indicated.
Highlighted immune genes mapping to 88–93 Mb QTL region on Ssa03.
| Gene name | Position |
|---|---|
| C-type lectin domain family 19, member A ( | 88422047–88426187 |
| Radical S-adenosyl methionine domain-containing protein 1, mitochondrial-like ( | 88965135–88966658 |
| NACHT, LRR and PYD domains ( | 89494115–89508816 |
| NACHT, LRR and PYD domains ( | 89871181–89874262 |
| Grass Carp Reovirus-Induced gene 1 ( | 89962846–89966991 |
| Mannose-binding protein C-like ( | 90310449–90311598 |
| Toll-like receptor 13 ( | 90560925–90564725 |
| NACHT, LRR and PYD domains ( | 91446779–91461776 |
| NACHT, LRR and PYD domains (sntx subunit beta) | 91655995–91658466 |
| NACHT, LRR and PYD domains (sntx subunit beta) | 91689071–91695362 |
| Putative oxidoreductase GLYR1 ( | 89116660–89121529 |
| Chloride channel-2C voltage-sensitive 7 ( | 89555699–89613839 |
| Meteorin, glial cell differentiation regulator* | 90812513–90828352 |
| Tubulin-specific chaperone D ( | 90860420–90875441 |
| 4-aminobutyrate aminotransferase ( | 89433950–89493945 |
Start and end map positions for each gene are shown (bp). Differentially expressed genes are marked with *.
Figure 3Map of the 88–93 Mb QTL region on Ssa03 showing Manhattan plot and genes that are differentially expressed in H-gEBV versus L-gEBV salmon (highlighted as red text) and trans-eQTL (highlighted in green text). SNP AX-88234566 at position 89963083 which was associated with relative SAV3 viral load (genome wide significance) mapped to a 3′UTR region of gig1 (highlighted in orange). The other two SNPs associated with relative SAV3 viral load mapped to intergenic regions (relative positions indicated by arrows).
Figure 4Boxplot of changes in expression of grass carp reovirus-induced gene 1 (Gig1-like), mapping to approximately 90.0 Mb along Ssa03. Plots show count of fragments per kilobase million (FPKM) for H-gEBV (green dot) and L-gEBV (red dot) fish challenged by intraperitoneal injection (IP) or cohabitation (CH) and sampled at 0- (naïve), 4- or 10-weeks post-infection.
Numbers of animals sampled for SAV3 RT-qPCR.
| gEBV | Challenge model | Naïve (W0) | W4 | W10 |
|---|---|---|---|---|
| High | IP | 67 (15) | 140 (5) | 140 (5) |
| CH | 141 (5) | 123 (5) | ||
| Low | IP | 68 (15) | 116 (5) | 109 (5) |
| CH | 125 (5) | 85 (5) | ||
| Total | 135 (30) | 522 (20) | 457 (20) |
Numbers of samples used for mRNA-seq in parentheses. Salmon with high or low estimated genomic breeding values (gEBV) were infected for the challenge test trials by intraperitoneal injection (IP) or cohabitation with infected fish (CH). Testing occurred one day before infection (W0), 4 weeks post-infection (W4) or 10 weeks post-infection (W10).